PL1632232T6 - Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu - Google Patents
Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitryluInfo
- Publication number
- PL1632232T6 PL1632232T6 PL05108086T PL05108086T PL1632232T6 PL 1632232 T6 PL1632232 T6 PL 1632232T6 PL 05108086 T PL05108086 T PL 05108086T PL 05108086 T PL05108086 T PL 05108086T PL 1632232 T6 PL1632232 T6 PL 1632232T6
- Authority
- PL
- Poland
- Prior art keywords
- amino
- cyanoethenyl
- benzonitrile
- dimethylphenyl
- pyrimidinyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20043578A MY169670A (en) | 2003-09-03 | 2004-09-02 | Combinations of a pyrimidine containing nnrti with rt inhibitors |
PCT/EP2004/052028 WO2005021001A1 (en) | 2003-09-03 | 2004-09-03 | Combinations of a pyrimidine containing nnrti with rt inhibitors |
EP05101467 | 2005-02-25 | ||
EP05108086.9A EP1632232B3 (en) | 2004-09-02 | 2005-09-02 | Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile |
Publications (2)
Publication Number | Publication Date |
---|---|
PL1632232T3 PL1632232T3 (pl) | 2011-10-31 |
PL1632232T6 true PL1632232T6 (pl) | 2022-06-27 |
Family
ID=34940340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05108086T PL1632232T6 (pl) | 2004-09-02 | 2005-09-02 | Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR101284361B1 (pl) |
AU (1) | AU2005279158C1 (pl) |
CA (1) | CA2577288C (pl) |
PL (1) | PL1632232T6 (pl) |
WO (1) | WO2006024668A1 (pl) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
SG170073A1 (en) * | 2006-01-20 | 2011-04-29 | Tibotec Pharm Ltd | Long term treatment of hiv infection |
TWI494133B (zh) | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | 重組用粉末 |
CN101784263B (zh) * | 2007-06-08 | 2012-11-07 | 贝林格尔.英格海姆国际有限公司 | 奈韦拉平的延长释放制剂 |
AU2008274185B2 (en) * | 2007-07-12 | 2014-07-03 | Janssen Sciences Ireland Uc | Crystalline form of (E) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
MX356891B (es) | 2010-01-27 | 2018-06-19 | Viiv Healthcare Co | Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapéuticos. |
UA114075C2 (xx) | 2010-11-19 | 2017-04-25 | БАГАТОШАРОВА ТАБЛЕТКА, ЩО МІСТИТЬ РИЛПІВІРИН HCl, ЕМТРИЦИТАБІН І ТЕНОФОВІРУ ДИЗОПРОКСИЛФУМАРАТ | |
WO2012125993A1 (en) | 2011-03-17 | 2012-09-20 | Teva Pharmaceutical Industries Ltd. | Solid state forms of rilpivirine base, and rilipivirine salts |
EP2755959B1 (en) * | 2011-09-16 | 2018-05-16 | Hetero Research Foundation | Rilpivirine hydrochloride |
EP2604593A1 (en) * | 2011-12-14 | 2013-06-19 | Sandoz AG | Polymorph of Rilpivirine hydrochloride and its use as antiviral |
WO2013087794A1 (en) * | 2011-12-14 | 2013-06-20 | Sandoz Ag | Polymorph of rilpivirine hydrochloride and its use as antiviral |
SI3528791T1 (sl) | 2016-10-24 | 2024-04-30 | Janssen Sciences Ireland Unlimited Company | Disperzibilne sestave |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY169670A (en) * | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
JO3429B1 (ar) * | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
JP4822707B2 (ja) * | 2002-08-09 | 2011-11-24 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 4−[[4−[[4−(2−シアノエテニル)−2,6−ジメチルフェニル]アミノ]−2−ピリミジニル]アミノ]ベンゾニトリルの製造方法 |
-
2005
- 2005-09-02 CA CA2577288A patent/CA2577288C/en active Active
- 2005-09-02 PL PL05108086T patent/PL1632232T6/pl unknown
- 2005-09-02 KR KR1020077006837A patent/KR101284361B1/ko active IP Right Review Request
- 2005-09-02 AU AU2005279158A patent/AU2005279158C1/en active Active
- 2005-09-02 WO PCT/EP2005/054342 patent/WO2006024668A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2005279158B2 (en) | 2010-06-17 |
CA2577288A1 (en) | 2006-03-09 |
KR101284361B1 (ko) | 2013-07-15 |
CA2577288C (en) | 2010-11-30 |
AU2005279158A1 (en) | 2006-03-09 |
KR20070074555A (ko) | 2007-07-12 |
AU2005279158C1 (en) | 2010-12-16 |
PL1632232T3 (pl) | 2011-10-31 |
WO2006024668A1 (en) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1632232T6 (pl) | Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu | |
HK1129671A1 (en) | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6- dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
CY2016050I1 (el) | Αλας του 4-[[4-[[4-(2-κυανοαιθενυλο)-2,6-διμεθυλοφαινυλο]αμινο]-2-πυριμιδινυλο]αμινο]βενζονιτριλιου | |
IL202363A0 (en) | Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
NO2014030I1 (no) | (E)-4-[[4-[[4-(2-cyanoetenyl)-2,6-dimetylfenyl]-amino]-2-pyrimidinyl]-amino]-benzonitril("Rilpivirine") samt enhver terapeutisk form derav som er dekket av det aktuelle patentet så som farmasøytisk akseptable salter av Rilpivirie innbefattende hydrokloridsaltet av Rilpivirine, og emtricitabine. | |
TWI341310B (en) | Improved production of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid calcium salt | |
AP2487A (en) | Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile | |
AP2296A (en) | Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile. | |
HK1112862A1 (pl) |